B cell receptor inhibitor causes chronic lymphocytic leukemia remission

Sunday, December 11, 2011 - 14:30 in Health & Medicine

A new, targeted approach to treating chronic lymphocytic leukemia has produced durable remissions in a Phase I/II clinical trial for patients with relapsed or resistant disease, researchers report.

Read the whole article on Science Daily

More from Science Daily

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net